In addition, a decreased expression of E-cadherin and β-catenin, as confirmed by immunohistochemistry, are important prognostic markers in patients with bladder carcinoma [95], and were linked with high grade and invasive stage of bladder carcinoma [96]. Here, CDH1 is linked to urinary bladder carcinoma.